SCHEMBL3264221

SCHEMBL3264221

CC1(C)OB(c2ccc(CN3CCC(F)(F)CC3)c(F)c2)OC1(C)C

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 1/20 0.49
KDM4E B2RXH2 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
LPL P06858 2/20 0.38
LIPG Q9Y5X9 2/20 0.38
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CXCR3 P49682 6/20 0.35
IDH1 O75874 1/20 0.35
HRH3 Q9Y5N1 2/20 0.34
ACHE P22303 1/20 0.34
CYP2A13 Q16696 1/20 0.34
POLB P06746 1/20 0.34
HTT P42858 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19211744 0.88 KDM4E (0.52) ROCK1KDM4ESMN1; SMN2LPLLIPG
SCHEMBL21644162 0.87 KDM4E (0.55) ROCK1KDM4ESMN1; SMN2LPLLIPG
SCHEMBL428922 0.86 CYP2A13 (0.50) ROCK1KDM4ESMN1; SMN2LPLLIPG
SCHEMBL18579955 0.86 ROCK1 (0.53) ROCK1KDM4ESMN1; SMN2LPLLIPG
SCHEMBL20680449 0.85 ROCK1 (0.47) ROCK1KDM4ESMN1; SMN2LPLLIPG
SCHEMBL3264764 0.85 ROCK1 (0.52) ROCK1KDM4ESMN1; SMN2LPLLIPG
SCHEMBL20198185 0.85 ROCK1 (0.49) ROCK1KDM4ESMN1; SMN2LPLLIPG
SCHEMBL2798956 0.83 ROCK1 (0.50) ROCK1KDM4ESMN1; SMN2LPLLIPG
SCHEMBL13517081 0.81 ROCK1 (0.48) ROCK1KDM4ESMN1; SMN2LPLLIPG
SCHEMBL3263593 0.81 ROCK1 (0.50) ROCK1KDM4ESMN1; SMN2LPLLIPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010010184-A1 [1, 2, 4] TRIAZOLO [1, 5-A] PYRIDINES AS JAK INHIBITORS GALAPAGOS NV (BE) 2010-01-28 WO disclosed
WO-2010010189-A1 NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2010-01-28 WO disclosed